Roivant Sciences Ltd (NAS:ROIV)
$ 11.94 -0.18 (-1.49%) Market Cap: 8.83 Bil Enterprise Value: 3.66 Bil PE Ratio: 2.15 PB Ratio: 1.62 GF Score: 41/100

Roivant Sciences Ltd Investor Day 2022 Transcript

Sep 28, 2022 / 03:00PM GMT
Release Date Price: $3.33 (+7.07%)
Paul Davis
Roivant Sciences, Inc. - Head of Communications

Great. Good morning, (foreign language), and welcome to Roivant Investor Day 2022. I'm Paul Davis, the Head of Communications at Roivant, and we're so excited you could join us today.

We'll be making certain forward-looking statements during today's presentation that reflect our current views and expectations, including those related to our financial performance and the potential attributes of our products and our product candidates. As always, we strongly encourage you to review the risk factors and other information that we have filed with the SEC for more information regarding these forward-looking statements and related risks and uncertainties.

We will be collecting questions over the course of the event for a Q&A session at the end. (Operator Instructions) Without further ado, I'll hand things over to our CEO, Matt Gline.

Matthew Gline
Roivant Sciences Ltd. - CEO & Director

Thank you, Paul, and good morning, everybody. We have an action-packed day with a bunch of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot